Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro. - Wikidata - awgldk - TriplyDB

Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro.

Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro.

http://www.wikidata.org/entity/Q35598050

about

Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors Expression and characterization of transforming growth factor alpha precursor protein in transfected mammalian cells Preimplantation embryo development in vitro: cooperative interactions among embryos and role of growth factors Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle Opposite effects of transforming growth factor alpha and epidermal growth factor on mouse placental lactogen I secretion.Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures.A chinese herbal decoction, danggui buxue tang, stimulates proliferation, differentiation and gene expression of cultured osteosarcoma cells: genomic approach to reveal specific gene activation Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo.Expression of epidermal growth factor and transforming growth factor alpha in interfacial membranes retrieved at revision total hip arthroplasty Tumor necrosis factor-beta and hypercalcemia.An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin Expression of transforming growth factor alpha (TGF-alpha) gene in mouse embryonic development.Transforming growth factor alpha and epidermal growth factor levels in normal human gastrointestinal mucosa.Chemical and biological assessment of angelica roots from different cultivated regions in a chinese herbal decoction danggui buxue tang Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases.Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells.Epidermal growth factor signalling and bone metastasis.Growth factors as active participants in carcinogenesis: a perspective.Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.Growth factors and the skeletal system.In vitro estrogenic activity of formononetin by two bioassay systems.Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo.Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.Transforming growth factor-alpha increases tyrosine phosphorylation of microtubule-associated protein kinase in a small intestinal crypt cell line (IEC-6).Production and response of a human prostatic cancer line to transforming growth factor-like molecules.Macromolecular osteolytic factor synthesised by squamous carcinoma cell lines from the head and neck in vitro is interleukin 1.Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.Expression of transforming growth factor-alpha in primary human colon and lung carcinomas.Immunoelectron microscopic localisation of transforming growth factor alpha in rat colon In vitro comparison of bioabsorbable and non-resorbable membranes in bone regeneration.Engineering dynamics of growth factors and other therapeutic ligands.Gene expression profiles in guided bone regeneration using combinations of different biomaterials: a pilot animal study.Rescue of a cherubism bone marrow stromal culture phenotype by reducing TGFβ signaling.

P2860

Q28359872-349D4500-FDC9-447E-ADCA-568A1DD05EF8 Q28574332-28315470-8E62-47AF-9870-DD20CD39FDF2 Q33643182-6E8CBEE3-E236-4783-AFB6-E4376262A318 Q34359163-EFC4928B-4462-4DE7-A0F4-D1448DC856E8 Q34507075-0314652B-BD51-4C86-88B3-FC2B6D75E1B3 Q34540942-11D81183-65D0-4F4D-B2EF-DA466FBD1C18 Q34566442-5EE49064-D5BD-44AB-926A-D71C98968BA2 Q35105437-23F9B2D5-D7F9-4422-B2A9-E8878D23A314 Q35229908-6A5B9317-F768-40EC-90F1-40F6CB7C39E4 Q35548932-187D5E0B-F3F6-4E1F-AA7B-4A8504B1DAE5 Q35664715-399B5400-CF7F-428C-A465-47BE9FD3A47F Q36221404-C4942C64-5BDF-413A-BF92-7B9F38C38536 Q36267468-27EB31E7-1BD2-4544-AC10-EC645E623CD4 Q36467897-6359D9BF-F8A8-4120-8150-DF4D0A14175C Q36622619-B607658F-8FC8-4794-8305-B53AE868C045 Q36745372-58FDDD10-BBFA-4103-BC49-CA820BC52CC6 Q37302910-53408C2B-D084-450E-9941-ACFBDCF632D7 Q37362838-313BBA2E-2BBA-4F93-A5B5-888A6E0023D7 Q37386180-54BF2C2F-C3E5-4FB0-B74A-25824BD57C25 Q37654767-ED04DB47-B9F0-49AE-A0BE-AC5F8ED92279 Q37676697-734F748C-8D86-439A-9DA2-E0EA8F9EAA2A Q37968256-59578528-584A-48C6-88F0-16742B407DED Q38731894-CB47865F-856C-4FD2-84DD-CBC467E30854 Q40203006-5C76D4E5-E40F-4AEC-900D-8F663F22449F Q41022124-7E3C55C6-F6EE-4DEA-919C-80F28139CC75 Q41225764-223616BB-FE9E-4678-A7E0-E1B0938BB1F8 Q41435438-0B333FA9-02BD-418B-9C75-A027B9BCE848 Q41719174-554C61EB-D555-4538-87DB-FEAFC23EE122 Q41860394-EDCF6D13-DCC3-4E67-BF23-FA0E7EE49033 Q41968752-DC29EBF3-06B7-445D-9F43-06ECF83B916B Q42087783-80D97EFF-3A5F-488B-BE20-057490F059B9 Q42142901-D1CAD9F4-2C10-4E95-8D41-FF3F2C40D5E0 Q43673805-A6BFFFF6-0967-4456-9B6A-6B2DA480F174 Q45878993-4264F89D-ACB7-4407-B7F0-8F95DFCBEE90 Q48219622-26C1551D-6879-490C-A2CD-87275CCDC706 Q51741155-F5F89A79-46DE-49F8-8195-C32F45386C28

P2860

Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro.

http://www.wikidata.org/entity/Q35598050

description

1986 nî lūn-bûn

@nan

1986年の論文

@ja

1986年論文

@yue

1986年論文

@zh-hant

1986年論文

@zh-hk

1986年論文

@zh-mo

1986年論文

@zh-tw

1986年论文

@wuu

1986年论文

@zh

1986年论文

@zh-cn

name

Human recombinant transforming ...... d inhibits formation in vitro.

@ast

Human recombinant transforming ...... d inhibits formation in vitro.

@en

type

label

Human recombinant transforming ...... d inhibits formation in vitro.

@ast

Human recombinant transforming ...... d inhibits formation in vitro.

@en

prefLabel

Human recombinant transforming ...... d inhibits formation in vitro.

@ast

Human recombinant transforming ...... d inhibits formation in vitro.

@en

P1433

Q35598050-F7EF6A05-C505-4FDA-A7DB-18910F0BBA1E

P1476

Q35598050-2227AD94-EFB3-477F-ADB8-D6798461657C

P2093

Q35598050-135503D3-EDF2-4054-83ED-6F24A2C5B2C9

Q35598050-400F5130-B6F5-4228-A63A-830E8CAB3897

Q35598050-4AB7F11C-A541-40E6-A01E-DAAD5700441E

Q35598050-98F0B56E-D8CE-4FE6-B76E-CC8C3A738D62

Q35598050-C5A42C8E-4F5A-4120-BB8A-535A25BE44F2

Q35598050-D338F8CD-B9C1-4F99-8DF4-49AE44E33075

Q35598050-E90F98C9-7D1A-4F02-A6F3-9FBCAC214669

Q35598050-FED4737F-21B7-4156-88B0-5520750523CA

P2860

Q35598050-03F1186B-02E9-455F-87AC-5CE3759CDB5C

Q35598050-26117EE4-E13C-44E9-B2FE-405C02EC72B3

Q35598050-3D4BD0CF-3415-4616-85F0-5516FBF7C90B

Q35598050-3DD3F266-2566-4F55-AB99-86B86E25E3AA

Q35598050-463A834F-F3DB-4E91-8C20-0C86610582CE

Q35598050-54B3E248-F66C-4E1F-9AFE-7F1192D2A98F

Q35598050-5ECD7E11-9FC8-4189-A25E-4EA14926675C

Q35598050-64EA2A29-4767-4DD2-9318-805DB6C8336E

Q35598050-67A49C8A-61C3-4E53-933E-2C12A1895E70

Q35598050-6BB14273-E58D-4C79-8234-76D395CB19F5

P304

Q35598050-6DFDC7F3-C606-4D6B-96D5-ABB44440BBED

P31

Q35598050-0A2F3A7B-EC0D-455E-831A-B7C73C338794

P356

Q35598050-9E56B484-5D97-4254-9E11-60B288A8733A

P407

Q35598050-A6325197-39BF-4409-8BBF-389110238E8D

P433

Q35598050-B8955FFB-2A70-4C11-9514-74B605224CF0

P478

Q35598050-EDB8B20B-D7C5-479A-B59E-07E4D2E52770

P577

Q35598050-109736EB-77B2-4563-9A9A-08748658EB74

P5875

Q35598050-CFF62FCA-BD5A-477E-B27E-9D2BD2723EAA

P698

Q35598050-B55B6166-5FE9-4807-9BB3-154E40237E52

P932

Q35598050-DEFF6BC9-C6DD-41FA-99BE-E1BF443FAA61

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Human recombinant transforming ...... d inhibits formation in vitro.

@en

P2093

D D Smith

http://www.w3.org/2001/XMLSchema#string

G R Mundy

http://www.w3.org/2001/XMLSchema#string

J Harrod

http://www.w3.org/2001/XMLSchema#string

K J Ibbotson

http://www.w3.org/2001/XMLSchema#string

M E Winkler

http://www.w3.org/2001/XMLSchema#string

M Gowen

http://www.w3.org/2001/XMLSchema#string

R Derynck

http://www.w3.org/2001/XMLSchema#string

S D'Souza

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy

Human transforming growth factor-alpha: precursor structure and expression in E. coli.

BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE.

Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor.

Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors.

Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.

Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria.

The hormonal and local regulation of bone formation.

The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.

P304

2228-2232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.83.7.2228

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

1986-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19670141

http://www.w3.org/2001/XMLSchema#string

P698

3485799

http://www.w3.org/2001/XMLSchema#string

P932

323265

http://www.w3.org/2001/XMLSchema#string